Oct 2015: Puridify completes Series A funding for commercialisation of single-use nanofibre-based purification technology

Platform technology set to transform purification in bioprocess manufacturing

London, UK – 21 October 2015Puridify Limited (“Puridify”), developers of novel bioprocessing purification technologies for industrial biomolecule manufacture, today announced the closing of a £2.2 million Series A funding round. This follow-on investment by existing investors Imperial Innovations, SR One and UCL Business, brings the total raised including grant funding to £8 million, and is a strong expression of confidence in the company and the progress of its proprietary nanofibre purification platform, FibroSelect.

Read more…